IP Verse

Amgen vs. Sanofi Aventis Deutschland - UPC_COA_528/2024

The case UPC_COA_528/2024 was filed by the plaintiff Amgen against the defendant Sanofi Aventis Deutschland on 13 Sep, 2024.

Case Timeline

13 Sep, 2024
Case Filed
18 Mar, 2025
Interim Conference
18 Mar, 2025
Oral Procedure
Today Nov 1, 2025
Decision

Case Details

    Case Number:

    UPC_COA_528/2024

    Patent Number:

    EP3666797

    Filing Date:

    13 Sep, 2024

    Proceeding Type:

    Appeal

    Case Phase:

    Oral Phase

    Plaintiffs:

    • Amgen

    Plaintiff Representative:

    • Koen Bijvank

    Defendants:

    • Sanofi Aventis Deutschland

    Defendant Representative:

    • Daniel Wise

    Judges:

    • Cornelis Schüller
    • Ingeborg Simonsson
    • Patricia Rombach
    • Rainer Friedrich
    • Rian Kalden

    Court Division:

    Appeal Instance - Seat - Luxembourg

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Oct 30, 2025
DateTitle

Notify me when new UPC document is filed

Sep 22, 2025Action.Phasechange
Sep 22, 2025Action.Phasechange
Sep 22, 2025Action.Phasechange
Aug 13, 2025Hearing Reference
Aug 5, 2025Schedule For Oral Hearing
Jun 26, 2025Receipt
Jun 25, 2025D102 Decision Opposition Division Of 21 May And Minutes Of The Oral Proceedings Held On 31 March 3 April
Jun 25, 2025Comments On The Decision Of The Od In Opposition
Jun 25, 2025C133
Jun 25, 2025C132
Jun 25, 2025C131
Jun 25, 2025C130
Jun 25, 2025C129
Jun 25, 2025C128
Jun 25, 2025C127
Jun 25, 2025C126
Jun 25, 2025C125
Jun 25, 2025C124
Jun 25, 2025C123
Jun 25, 2025C118
Jun 25, 2025.06.25 EP797Upc Appeal Letter To Coa Commenting On Od Decision
May 26, 2025Outcome Of The Order
May 26, 2025Order On Time Extension
May 22, 2025Receipt
May 22, 2025.05.22 Request For Extension Deadline For Providing Comments On Od Decision Signed
May 6, 2025Summons
Apr 29, 2025Response To Order DATED 17 April
Apr 29, 2025Reply To Coa Order
Apr 29, 2025Annex Evidence Of Prior Commitment
Apr 17, 2025Template Order
Apr 17, 2025Case Management Order
Mar 18, 2025Summon Oral Hearing
Mar 18, 2025Order On Ic
Mar 18, 2025Interim Procedure Closure
Mar 18, 2025Interim Conference Decision
Feb 17, 2025C122A
Feb 17, 2025C122
Feb 17, 2025C121A
Feb 17, 2025C121
Feb 17, 2025C120A
Feb 17, 2025C120
Feb 17, 2025C119A
Feb 17, 2025C119
Feb 17, 2025C118A
Feb 17, 2025C118
Feb 17, 2025C117A
Feb 17, 2025C117
Feb 17, 2025C116A
Feb 17, 2025C116
Feb 17, 2025C115A
Feb 17, 2025C115
Feb 17, 2025Acknowledgement Of Lodging
Feb 17, 2025.02.17 Statement Of Response Signed
Feb 11, 2025Summons To Oral Hearing
Feb 5, 2025Reply To Summons Coa
Feb 5, 2025Flight Booking
Feb 5, 2025.02.05 Submission On Appeal Hearing Date (Sanofi Rgn)
Jan 30, 2025Summons
Jan 27, 2025Comments
Jan 24, 2025Summons Tba Hearing
Jan 24, 2025Request Rescheduling Hearing
Jan 22, 2025Summons
Dec 11, 2024Panel Appointment
Nov 28, 2024Acknowledgement Of Lodging
Nov 15, 2024Statement Of Grounds Of Appeal
Nov 15, 2024D101
Nov 15, 2024D100
Nov 15, 2024Annex 3
Nov 15, 2024Acknowledgement Of Lodging
Oct 14, 2024Acknowledgement Of Lodging
Oct 14, 2024.10.14 Application To Change Details Of A Representative (Signed)
Oct 7, 2024Receipt
Oct 7, 2024Panel Appointment
Oct 7, 2024Formal Checks Notification Of Positive Outcome
Oct 7, 2024Acknowledgement Of Lodging
Oct 2, 2024Statement Of Appeal
Oct 2, 2024Rectified Statement Of Appeal
Oct 2, 2024Proof Of Payment
Oct 2, 2024Formal Checks Request For Correction
Sep 24, 2024Formal Checks Request For Correction
Sep 13, 2024Statement Of Appeal
Sep 13, 2024Proof Of Payment
Sep 13, 2024Acknowledgement Of Lodging

More cases involving EP3666797B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_3214/2025Jan 21, 2025Redacted Natural Person NameAmgen, Dehns, Redacted Natural Person Name, Sanofi Aventis Deutschland, Sanofi Aventis Groupe, Sanofi Winthrop Industrie
APL_51679/2024Sep 13, 2024AmgenSanofi Aventis Deutschland, Sanofi Aventis Groupe, Sanofi Winthrop Industrie
APL_51683/2024Sep 13, 2024AmgenRegeneron Pharmaceuticals

More cases involving Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_35200/2025Aug 21, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35086/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35087/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -

More cases involving Sanofi Aventis Deutschland

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_34328/2025Aug 5, 2025AmgenSanofi Aventis Deutschland
ORD_33148/2025Jul 17, 2025Sanofi Aventis DeutschlandStada Arzneimittel, Stada Nordic, Stadapharm
APP_32509/2025Jul 8, 2025Betapharm Arzneimittel, DR Reddys, Reddy PharmaSanofi Aventis Deutschland